A drug named Orfadin® (nitisinone) an oral suspension formulation for the treatment of Hereditary Tyrosinaemia type-1 (HT-1) has been granted a patent by the EPO. Hereditary Tyrosinaemia type-1 (HT-1) is a rare genetic disease affecting children. [More]
Sobi’s Orfadin® oral suspension granted European patent - Prometheus IP
prometheusip
Prometheus IP is a leading intellectual property service enterprise offering competent and economic Intellectual Property Rights (IPR) solutions which include Patents, Designs, Copyrights and Trademarks.
Our Wide Range of Services
Hyderabad
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
Get in touchPrometheus IP Social
Copyright Prometheus IP. All rights reserved.
Copyright Prometheus IP. All rights reserved.